Skip to content

Enteer™ ENB-275-20-150Recalls & reported problems

Ev3, Inc · CATH ENB-275-20-150 CTO RE-ENTRY V03 · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00821684073780), received between Sep 17, 2019 and Sep 17, 2019 — classified as 1 malfunction.

The most frequently reported specific device problem is “Burst Container or Vessel” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Burst Container or Vessel1
  • Positioning Problem1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 17, 2019Burst Container or Vessel; Positioning Problem; Burst Container or Vessel; Positioning Problem

    PHYSICIAN INTENDED TO USE AN ENTEER RE-ENTRY BALLOON CATHETER WITH AN ENTEER GUIDEWIRE DURING TREATMENT OF A SEVERELY CALCIFIED VESSEL. THE DEVICES WERE UNSUCCESSFUL IN CROSSING. IT IS REPORTED DUE TO THE EXTREME CALCIFICATION THE BALLOON CATHETER BURST AND THE GUIDEWIRE TIP WAS DAMAGED. A SECOND ENTEER RE-ENTRY BALLOON CATHETER AND ENTEER GUIDEWIRE WAS THEN ATTEMPTED TO BE USED WITH THE SAME OUTCOME. THE PROCEDURE WAS ABORTED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 9075214 ↗

Other Catheter for crossing total occlusions devices

All Catheter for crossing total occlusions devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page